PMC:7461420 / 30871-31115
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T168 | 88-95 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
| T169 | 105-109 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
| T170 | 216-225 | Body_part | denotes | endosomal | http://purl.org/sig/ont/fma/fma67180 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T176 | 75-79 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T347 | 12-13 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T348 | 105-109 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
| T349 | 177-179 | http://purl.obolibrary.org/obo/CLO_0001000 | denotes | 35 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T278 | 88-95 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T41 | 105-116 | http://purl.obolibrary.org/obo/GO_0140253 | denotes | cell fusion |
| T42 | 105-116 | http://purl.obolibrary.org/obo/GO_0045026 | denotes | cell fusion |
| T43 | 105-116 | http://purl.obolibrary.org/obo/GO_0000768 | denotes | cell fusion |
| T44 | 105-116 | http://purl.obolibrary.org/obo/GO_0000747 | denotes | cell fusion |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 981 | 75-83 | Species | denotes | SARS‐CoV | Tax:694009 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T287 | 0-244 | Sentence | denotes | However, at a higher concentration (100 µM), inhibition of viral entry via SARS‐CoV‐1 S protein‐mediated cell fusion never exceeded 65% (inhibition efficiency), indicating that 35% of entry events take place via the endosomal cathepsin pathway. |